Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes
From Pubdrug
(List of links)
< Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetesThe following pages link to here:
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500). View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500).
